Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

[1]  G. Bastert,et al.  Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  R. Rubens,et al.  Clinical course and prognostic factors following bone recurrence from breast cancer. , 1998, British Journal of Cancer.

[3]  D. Wallwiener,et al.  Das primär ossär metastasierte Mammakarzinom , 1997 .

[4]  M. Piccart,et al.  Use of bisphosphonates in cancer patients. , 1996, Cancer treatment reviews.

[5]  W. D. Ray.  4. Modelling Survival Data in Medical Research , 1995 .

[6]  D. Collett.  Modelling Survival Data in Medical Research , 1994 .

[7]  R. Coleman.  Evaluation of bone disease in breast cancer , 1994 .

[8]  J. Warwick,et al.  Parathyroid hormone related protein and skeletal morbidity in breast cancer. , 1992, European journal of cancer.

[9]  K. Yonenobu,et al.  Breast cancer with bone‐only metastases. Visceral metastases‐free rate in relation to anatomic distribution of bone metastases , 1991, Cancer.

[10]  O. S. Nielsen,et al.  Bone metastases: pathophysiology and management policy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Vallejo,et al.  Bone‐Only Versus Visceral‐Only Metastatic Pattern in Breast Cancer: Analysis of 150 Patients A GOCS Study , 1990, American journal of clinical oncology.

[12]  O. Kallioniemi,et al.  Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. , 1990, British Journal of Cancer.

[13]  C. Kamby.  The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. , 1990, Cancer treatment reviews.

[14]  K. Zedeler,et al.  Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action. , 1988, British Journal of Cancer.

[15]  H. Mouridsen,et al.  Clinical and radiologic characteristics of bone metastases in breast cancer , 1987, Cancer.

[16]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.

[17]  G M Clark,et al.  Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Terry L. Smith,et al.  Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy , 1986, Cancer.

[19]  J. Hainsworth,et al.  Metastatic breast cancer confined to the skeletal system: An indolent disease☆ , 1986 .

[20]  P. Hietanen,et al.  Survival after first recurrence in breast cancer. , 1986, European journal of cancer & clinical oncology.

[21]  O. Salazar,et al.  Prognosticators in recurrent breast cancer. A 15‐year experience with irradiation , 1984, Cancer.

[22]  L. Malmud,et al.  Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastases. , 1982, American journal of clinical oncology.

[23]  R. Rubens,et al.  Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. , 1981, European journal of cancer.

[24]  Brunner Kw,et al.  Prognostic factors in metastatic breast cancer. , 1981 .

[25]  M. Fey,et al.  Prognostic factors in metastatic breast cancer. , 1981, Cancer clinical trials.

[26]  G. Hortobagyi,et al.  Prognostic factors in metastatic breast cancer treated with combination chemotherapy. , 1979, Cancer research.

[27]  M. Francis,et al.  Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  F. Doyle,et al.  The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. , 1972, Clinical radiology.

[29]  G. Chisholm,et al.  18 fluorine total body scans in patients with carcinoma of the prostate. , 1971, British journal of urology.

[30]  A. Johnston.  Pathology of Metastatic Tumors in Bone , 1970, Clinical orthopaedics and related research.

[31]  R. Drury,et al.  Carcinomatous metastasis to the vertebral bodies , 1964, Journal of clinical pathology.

[32]  R. Drury,et al.  Carcinomatous metastasis tothevertebral bodies , 1964 .